financing
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.
Renovaro Nets $15M in Equity Financing, Announces Merger With BioSymetrics
The firm will use the money raised to accelerate its efforts in drug discovery and development, and in the development of cancer diagnostics.
Tempus AI Raises $300M in Debt Financing
Ares Credit funds served as the administrative agent on the incremental debt financing, which is intended to support Tempus' acquisition of Ambry Genetics.
Oncocyte Enters $29.1M Securities Purchase Agreement
The company expects the funds to be sufficient to complete development of its IVD diagnostic transplant assay program.
Mirxes Gets $40M Financing From CBC Group's R-Bridge to Support Global Expansion
The company is developing blood-based microRNA tests for early cancer detection and screening, with its flagship assay, GastroClear, already approved as an IVD in Singapore.
Nov 26, 2024
Nov 22, 2024
OneCell Diagnostics Raises $16M in Series A Round
Nov 5, 2024
PrognomiQ Closes $34M Series D Round
Oct 10, 2024
Cytovale Raises $100M in Series D Round
Oct 10, 2024
Sep 24, 2024